Group One Trading’s Werewolf Therapeutics HOWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-200
Closed -$394 – 8553
2025
Q3
$394 Sell
200
-1,000
-83% -$1.37K ﹤0.01% 8170
2025
Q2
$1.31K Sell
1,200
-2,500
-68% -$2.57K ﹤0.01% 7513
2025
Q1
$3.6K Sell
3,700
-9,100
-71% -$11.9K ﹤0.01% 6780
2024
Q4
$18.9K Buy
+12,800
New +$26.1K ﹤0.01% 5724

Other funds holding HOWL

Group One Trading's HOWL Position: Q3 2026 in Review

Group One Trading sold out of Werewolf Therapeutics (HOWL) in Q3 2026, closing a stake of 1,871 shares — an estimated $673 sold.

Group One Trading first reported a position in HOWL in Q2 2022 and held it in 7 quarters. The position peaked at $5.26K in Q3 2025. 46 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.

  • Group One Trading reported no remaining Werewolf Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 1,871 Werewolf Therapeutics shares in Q3 2026, an estimated $673.
  • Group One Trading first reported a position in Werewolf Therapeutics in Q2 2022 and held it in 7 quarters.
  • Group One Trading's Werewolf Therapeutics position peaked at $5.26K in Q3 2025.
  • 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.